News & Updates
Filter by Specialty:
Show Multimedia Only

Statins augment survival in prostate cancer patients on an ARPI
10 Oct 2025
byJairia Dela Cruz
Among prostate cancer patients receiving treatment with the androgen receptor pathway inhibitor (ARPI) apalutamide, those who also use statins appear to have longer overall survival, according to a study.
Statins augment survival in prostate cancer patients on an ARPI
10 Oct 2025
OnabotulinumtoxinA as effective as, safer than pharmacotherapy for OAB
02 Oct 2025
byStephen Padilla
Women with refractory overactive bladder (OAB) may improve their symptoms by using either intradetrusor onabotulinumtoxinA or combined pharmacotherapy with solifenacin and mirabegron, suggests a study.